US FDA’s Drug Division Undergoes Leadership Transition to Strengthen Integrity and Innovation
The U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,
Read MoreThe U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,
Read MoreAs COP30 approaches, Bill Gates urges world leaders to rethink the climate agenda — focusing on resilience, health, and equity
Read More